Metraipolis › archive › dc_00a0013c7be2

[Efficacy and Safety of High-dose Furmonertinib plus Intrathecal Pemetrexed for EGFR-mutant Non-small Cell Lung Cancer with Leptomeningeal Metastasis] — Europe PMC PMID:41777061

Source: Europe PMC (chi)
Original: https://europepmc.org/article/MED/41777061
DOI: 10.3779/j.issn.1009-3419.2025.101.24
License (as archived): solo-consultazione
Archived: 2026-11-08T01:09:39.641Z
SHA-256 of the archived text: b736dab0cb653c3e272ca0a86da9ccde6138756b949fb62c06b9853890e31623
Stable URL of this page: https://metraipolis.com/documento/dc_00a0013c7be2

How to cite

[Efficacy and Safety of High-dose Furmonertinib plus Intrathecal Pemetrexed for EGFR-mutant Non-small Cell Lung Cancer with Leptomeningeal Metastasis] — Europe PMC PMID:41777061 — Europe PMC (chi), https://europepmc.org/article/MED/41777061 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_00a0013c7be2 (Metraipolis archive dc_00a0013c7be2, sha256 b736dab0cb653c3e272ca0a86da9ccde6138756b949fb62c06b9853890e31623)

BibTeX

@misc{dc00a0013c7be2,
  title = {[Efficacy and Safety of High-dose Furmonertinib plus Intrathecal Pemetrexed for EGFR-mutant Non-small Cell Lung Cancer with Leptomeningeal Metastasis] — Europe PMC PMID:41777061},
  howpublished = {Europe PMC (chi)},
  url = {https://europepmc.org/article/MED/41777061},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_00a0013c7be2; sha256 b736dab0cb653c3e272ca0a86da9ccde6138756b949fb62c06b9853890e31623},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41777061. Agents can read the archived copy with the MCP tool read_document.